The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Activities

CDDF offers workshops, conferences and webinars that bring stakeholders involved in cancer drug development into a productive dialogue in a neutral, non-competitive space. CDDF holds multiple activities and initiatives in collaboration with regulators from both the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) and other regulatory agencies, academic researchers from around the globe, pharmaceutical companies, and patient advocates.

=

Upcoming meetings

=

Past meetings

CDDF Forum

CDDF Spring Conference


The CDDF Spring Conference is held every year in the Netherlands. This meeting considers recent achievements and brainstorms current issues in cancer drug development to gauges which topics warrant further discussion at workshops.

The conference brings together leaders in the world of innovative cancer therapy development from academia, the pharmaceutical industry, regulatory authorities, policymakers and patient advocacy groups to work toward improving cancer treatment.

The 12th edition will take place from 8 to 10 February 2021, in Noordwijk aan Zee (NL) to discuss the current and future challenges in Innovative oncology drug development.

CDDF Multi-stakeholder Workshops

In addition to the Spring conference, the CDDF organises workshops to facilitate multi-stakeholder collaboration to address topical issues in the cancer research field such as biomarkers, minimal residual disease, oncology clinical trial design and innovative oncology drugs. 

 

 

 

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

info@cddf.org
Tel: +32 2 880 62 70